Biologics
Streamlines biotherapeutics discovery by integrating workflows and automating tasks for antibodies, ADCs, TCRs, CAR-Ts, and AAVs.
Overview
Genedata Biologics is a comprehensive platform designed to streamline the discovery of biotherapeutics, including bispecifics, ADCs, TCRs, CAR-Ts, and AAVs. It is widely adopted in the industry for its ability to integrate end-to-end workflows and automate routine tasks, allowing research teams to focus on scientific innovation.
The platform uniquely integrates and centrally manages data across biopharma workflows and instruments, supporting a wide range of formats such as antibodies, bi- or multi-specifics, ADCs, novel scaffolds, and therapeutic proteins, as well as engineered therapeutic cell lines like TCRs and CAR-T cells.
Genedata Biologics is chosen by leading organizations for its extensive process coverage, supporting diverse large-molecule processes and technologies. It meets requirements across all phases of biologics discovery, including novel multi-specific antibody formats and innovative automation methods.
Applications
- Bispecific Antibody Discovery: Optimizes discovery and automates downstream processes, significantly boosting throughput by identifying optimal antigen binder combinations and formats.
- Cell Therapy R&D: Streamlines R&D with tools for designing and evaluating cell-based therapeutic modalities, fully automating sample handling and testing procedures.
- Gene Therapy Workflows: Accelerates R&D by supporting workflows from serotype optimization to virus packaging and testing, tracking all samples and associated data.
- ADC Discovery and Development: Manages large panels of ADC candidates, integrating analytics and functional assay results to streamline the discovery process.
- Vaccine Development: Improves efficiency and reduces costs in vaccine discovery, supporting emerging technologies like synthetic self-amplifying mRNA.
- RNA Therapeutics: Revolutionizes RNA therapeutics design and development, providing critical data infrastructure for faster development.
- B-Cell-Derived Therapeutic Antibody Discovery: Facilitates R&D by tracking data and managing experiments within a centralized platform.
- Developability Risks: Minimizes risks by assessing candidates' risk profiles and critical quality attributes.
Features
- High-Throughput Screening: Automates screening of biotherapeutic candidates, improving early discovery workflows.
- Protein Engineering and Optimization: Supports efficient engineering and optimization of protein formats, including advanced tools for affinity maturation and humanization.
- Protein Production and Quality Control: Tracks and validates the protein production process, linking analytical characterization and QC data to samples.
- Unified Task Management: Enhances R&D efficiency by managing task scheduling and documenting request progress in real time.
- Centralized Tracking and Lifecycle Management: Provides integrated sample management, ensuring traceability and regulatory compliance.


